[CAS NO. 2125676-13-1]  DDR1-IN-4

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2125676-13-1]

Catalog
HY-114173
Brand
MCE
CAS
2125676-13-1

DESCRIPTION [2125676-13-1]

Overview

MDL-
Molecular Weight565.34
Molecular FormulaC23H20BrF3N6O3
SMILESO=C(NCC(F)(F)F)CN1C(C2(CCN(C(C3=CC=C(NN=C4)C4=N3)=O)CC2)C5=C1C=CC=C5Br)=O

For research use only. We do not sell to patients.

Summary

DDR1-IN-4 (Compound 2.45) is a selective and potent Discoidin Domain Receptor 1 (DDR1) autophosphorylation inhibitor, with IC 50 values of 29 nM and 1.9 μM for DDR1 and DDR2 , respectively [1] .


IC50 & Target

DDR1

29 nM (IC 50 )

DDR2

1900 nM (IC 50 )


In Vitro

DDR1-IN-4 (Compound 2.45) shows a clear dose-dependent inhibition of DDR1 phosphorylation in HT1080 cells overexpressing DDR1, with greater than 70% inhibition of phosphorylation at a concentration of 1 μM, and retaining selectivity over inhibition of DDR2 [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

DDR1-IN-4 (Compound 2.45, ip, 90 mg/kg) preserves renal function and reduces tissue damage in Col4a3 –/– mice (the preclinical mouse model of Alport syndrome) when employing a therapeutic dosing regime, indicating the real therapeutic value of selectively inhibiting DDR1 phosphorylation in vivo [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Col4a3 –/– mice, a mouse model phenocopying Alport syndrome [1] .
Dosage: 90 mg/kg.
Administration: Injected intraperitoneally daily.
Result: Resulted in a significant reduction of fibrosis evaluated by Picro Sirius Red, smooth muscle actin staining, and collagen I accumulation.
Significantly reduces the levels of pDDR1 in Col4a3 knockout mice compared to controls.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 250 mg/mL ( 442.21 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.7688 mL 8.8442 mL 17.6885 mL
5 mM 0.3538 mL 1.7688 mL 3.5377 mL
10 mM 0.1769 mL 0.8844 mL 1.7688 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (3.68 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (3.68 mM); Clear solution

* All of the co-solvents are available by MCE.